Literature DB >> 33582489

Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery.

Stefano Cosma1, Andrea Roberto Carosso2, Silvia Corcione3, Jessica Cusato4, Fulvio Borella1, Miriam Antonucci4, Luca Marozio1, Alberto Revelli1, Mario Preti1, Valeria Ghisetti5, Giovanni Di Perri6, Chiara Benedetto1.   

Abstract

We report herein the longest-lasting study of SARS-CoV-2 antibody profile in pregnancy, from first trimester-infection to delivery. Seventeen out of 164 pregnant women tested positive for COVID-19. Throughout pregnancy, the neutralizing antibody titer remained stable, whilst a significant decline in the non-neutralizing antibodies was observed after 16 weeks of gestation. All the newborns of women who developed IgG antibodies showed the presence of the same antibodies in arterial cord blood. Knowledge on the longevity and type of SARS-CoV-2 antibody response may help to guide vaccination strategies in pregnancy.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibodies; COVID-19 immunology; COVID-19 vaccines; Pregnancy; SARS-CoV-2

Year:  2021        PMID： 33582489     DOI： 10.1016/j.jri.2021.103285

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN： 0165-0378            Impact factor:   4.054


  6 in total

Review 1.  COVID-19 disease and vaccination in pregnant and lactating women.

Authors:  Marco A P Safadi; Julia Spinardi; David Swerdlow; Amit Srivastava
Journal:  Am J Reprod Immunol       Date:  2022-05-09       Impact factor: 3.777

2.  Pregnancy alters interleukin-1 beta expression and antiviral antibody responses during severe acute respiratory syndrome coronavirus 2 infection.

Authors:  Morgan L Sherer; Jun Lei; Patrick S Creisher; Minyoung Jang; Ramya Reddy; Kristin Voegtline; Sarah Olson; Kirsten Littlefield; Han-Sol Park; Rebecca L Ursin; Abhinaya Ganesan; Theresa Boyer; Nada Elsayed; Diane M Brown; Samantha N Walch; Annukka A R Antar; Yukari C Manabe; Kimberly Jones-Beatty; William Christopher Golden; Andrew J Satin; Jeanne S Sheffield; Andrew Pekosz; Sabra L Klein; Irina Burd
Journal:  Am J Obstet Gynecol       Date:  2021-03-30       Impact factor: 8.661

3.  Maternal-Fetal Implications of SARS CoV-2 Infection during Pregnancy, Viral, Serological Analyses of Placenta and Cord Blood.

Authors:  Souhail Alouini; Jerôme Guinard; Olivier Belin; Louis Mesnard; Evelyne Werner; Thierry Prazuck; Chantal Pichon
Journal:  Int J Environ Res Public Health       Date:  2022-02-13       Impact factor: 3.390

4.  Obstetric and neonatal outcomes after SARS-CoV-2 infection in the first trimester of pregnancy: A prospective comparative study.

Authors:  Stefano Cosma; Andrea Roberto Carosso; Jessica Cusato; Fulvio Borella; Luca Bertero; Marialuisa Bovetti; Federica Bevilacqua; Giulio Mengozzi; Raffaela Mazzone; Valeria Ghisetti; Giovanni Di Perri; Chiara Benedetto
Journal:  J Obstet Gynaecol Res       Date:  2021-11-23       Impact factor: 1.697

5.  Clinical, Laboratory, and Imaging Findings of Pregnant Women with Possible Vertical Transmission of SARS-CoV-2-Case Series.

Authors:  Marius Craina; Daniela Iacob; Mirabela Dima; Sandor Bernad; Carmen Silaghi; Andreea Moza; Manuela Pantea; Adrian Gluhovschi; Elena Bernad
Journal:  Int J Environ Res Public Health       Date:  2022-09-01       Impact factor: 4.614

6.  Persistence of infection-induced SARS-CoV-2 seropositivity throughout gestation.

Authors:  Cara Staszewski; Burton Rochelson; David A Krantz; Rachel P Gerber; Hannah Juhel; Shreya Reddy; Matthew J Blitz
Journal:  Am J Obstet Gynecol       Date:  2021-10-02       Impact factor: 8.661
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.